Multiple MyelomaФаза 2NCT06207799
Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma
Elranatamab, Lenalidomide, Plerixafor, Melphalan
265 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Leukemia, lymphoma, and myeloma265 studies
Multiple MyelomaФаза 2NCT06207799
Elranatamab, Lenalidomide, Plerixafor, Melphalan
B-Cell LymphomaPhase 1/2NCT05092451Papers
CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
Multiple MyelomaФаза 2NCT07284758
Cemsidomide, Dexamethasone
Recurrent Childhood Acute Myeloid LeukemiaPhase 1NCT06609928Papers
FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia
Multiple MyelomaФаза 2NCT06483100
Elrantamab, clonoSEQ
Recurrent Cutaneous T-Cell Non-Hodgkin LymphomaPhase 1/2NCT03011814Papers
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Clonal Cytopenia of Undetermined SignificanceФаза 2NCT05483010
Atorvastatin, Rosuvastatin
LymphomaФаза 2NCT05929612
Ultra Low Dose 4 Gy Radiation
Acute Lymphoblastic LeukemiaФаза 2NCT06533748Papers
Dexamethasone, Vincristine, Inotuzumab, Blinatumomab
Large B-cell LymphomaФаза 2NCT05464719Papers
Loncastuximab Tesirine
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Phase 1/2NCT01371630Papers
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
Recurrent Multiple MyelomaФаза 2NCT05847569
Belantamab Mafodotin, Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy
Newly Diagnosed Acute Myeloid LeukemiaPhase 1NCT04659616Papers
Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia
Cutaneous T-Cell LymphomaФаза 2NCT06698822
tofacitinib 2% cream
Refractory Diffuse Large B Cell Lymphoma (DLBCL)Фаза 2NCT04792489
zamtocabtagene autoleucel (MB-CART2019.1), Cyclophosphamide, Fludarabine, Bendamustine
Acute Myeloid LeukemiaФаза 2NCT05442216
Tagraxofusp, Azacitidine, Venetoclax
Non-Hodgkin LymphomaPhase 1NCT05098613Papers
Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
Multiple MyelomaPhase 1NCT06185751
CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma
Recurrent B-Cell Non-Hodgkin LymphomaФаза 2NCT06723457
Biospecimen Collection, Computed Tomography, Epcoritamab, Lenalidomide
C-Myc Rearranged High-Grade B-Cell Lymphoma or DLBCLPhase 1/2NCT06249191
Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma
Leukemia, Myeloid, AcuteФаза 2NCT07216443
Orca-T
Multiple MyelomaФаза 2NCT06083922
Cyclophosphamide, Bortezomib, Dexamethasone, Daratumumab
Acute Myelogenous LeukemiaФаза 2NCT05805605
Peripheral Blood Stem Cell Transplant, Allopurinol 300 MG, Fludarabine, Cyclophosphamide
Acute Myeloid Leukemia, AdultФаза 2NCT04050280
Cladribine, Cytarabine, and Granulocyte-Colony Stimulating Factor with Fractionated Gemtuzumab Ozogamicin (CLAG-GO)